Measurement strategies solubility

Avdeef, A. High-throughput measurements of solubility profiles. In Pharmacokinetic Optimization in Drug Research Biological, Physicochemical and Computational Strategies, Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. (eds.), VHCA, Zurich and Wiley-VCH, Weinheim, 2001, pp 305-325. 

If co-crystals are to solve solubility problems one must assess their true or thermodynamic solubility so that development strategies are guided by the fundamental properties of co-crystals. Measuring the solubility of co-crystals that generate supersaturation of the parent drug is often experimentally impossible due to conversion. Eutectic points, described in Section 11.4, provide a measure of co-crystal solubility under thermodynamic equilibrium conditions. The solution at the eutectic point is saturated with co-crystal and solution concentrations represent experimentally accessible thermodynamic solubility values. Once co-crystal solubility is determined at the eutectic, the solubility under different solution conditions (pH, co-former, micelle concentration) can be obtained from solubility models that consider the appropriate solution phase equilibrium expressions. 

Whatever the specific system or situation, the key issue in diffusion interphase adhesion is physical compatibility. This is once again, a thermodynamic issue and may be quantified in terms of mutual solubility. Most of the strategies for predicting diffusion interphase adhesion are based on thermodynamic compatibility criteria. Thus it is appropriate to review briefly the relevant issues of solution thermodynamics and to seek quantitative measures of compatibility between the phases to be bonded. 

The volume is divided into five sections. Part one looks at the experimental study of membrane permeability and oral absorption. In Part two, problems of measuring and prediction solubility, as one of the key determinants in the absorption process, will be discussed in detail. In the next part, progress in the science around transporter proteins and gut wall metabolism and their effect on the overall absorption process is presented. Part four looks at the in silico approaches and models to predict permeability, absorption and bioavailability. In the last part of the book, a number of drug development issues will be highlighted, which could have an important impact of the overall delivery strategies for oral pharmaceutical products. 

Poorly soluble compounds represent an estimated 60% of compounds in development and many major marketed drugs. It is important to measure and predict solubility and permeability accurately at an early stage, and interpret these data to help assess the potential for development of candidates. This requires developing an effective strategy to select the most appropriate tools to examine and improve solubility in each phase of development, and optimization of solid-state approaches to enhance solubility including the use of polymorphs, co-crystals, and amorphous solids. 

---